Updated:
Vedanta Capital
Vedanta Capital is a venture capital firm established in 2006 by industry veterans with a history of investing since the 1980s. The firm focuses on...
Vedanta Capital
Vedanta Capital is a venture capital firm established in 2006 by industry veterans with a history of investing since the 1980s. The firm focuses on technology-based products and services, innovative medical technologies, and disruptive business or consumer services. Vedanta Capital has made 24 investments, including a 2023 investment in Merlin, and has facilitated three portfolio exits, with ChannelInsight exiting in 2015.
General information
Firm type
Private Equity
Year founded
2006
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
Parag Saxena
Founding General Partner
Howard E. Goldstein
Founding General Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Vedanta Capital?
Investment decisions are driven by founding general partners Parag Saxena and Howard E. Goldstein. Saxena previously served as CEO and co-founder of Invesco Private Capital, where he oversaw billions in venture and growth investments. Goldstein also held senior roles at Invesco and brings operational experience from board positions at multiple portfolio companies. Together they form the core of Vedanta's investment committee.
How does Vedanta's cross-border strategy between the US and India work?
Vedanta invests in both US-based and India-based companies, often in software and technology-enabled services where the India connection provides either a development talent advantage or a large addressable market. Parag Saxena's personal network and history as one of the early institutional venture investors with an India thesis gives the firm sourcing advantages that generalist US-only firms cannot replicate. The firm evaluates opportunities in both countries through a single investment committee.
Which sectors does Vedanta explicitly avoid?
Vedanta does not invest in hard science or capital-intensive deep tech such as semiconductor fabrication, aerospace hardware, or drug discovery. The firm's investment team backgrounds are concentrated in enterprise software, SaaS, and technology-enabled business services, and the partnership has historically avoided sectors where the diligence process requires a fundamentally different scientific or regulatory expertise.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: